CME/CE
Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, women's health and more. And our CME library is continuously growing, every quarter.
16-30 of 1087
Why Staging TED Correctly Matters Even When CAS Is Low
MinuteCE®Why Staging TED Correctly Matters Even When CAS Is Low
Beyond IGF-1R: IL-6R Inhibition and Future Sequencing
MinuteCE®Beyond IGF-1R: IL-6R Inhibition and Future Sequencing
Comparing Trial Designs & Outcomes Across IGF-1R Therapies
MinuteCE®Comparing Trial Designs & Outcomes Across IGF-1R Therapies
Overcoming Real-World Barriers to TED Treatment
MinuteCE®Overcoming Real-World Barriers to TED Treatment
- advertisement
Understanding IGF-1R Inhibition: Mechanism & Clinical Implications
MinuteCE®Understanding IGF-1R Inhibition: Mechanism & Clinical Implications
Cracking the Code in Localized, nmCSPC: Risk, Treatment, and Timing
CME/CECracking the Code in Localized, nmCSPC: Risk, Treatment, and Timing
Closing the Gaps: Global Implementation of Lipid Guidelines
CME/CEClosing the Gaps: Global Implementation of Lipid Guidelines
The Future of mCSPC: Molecular Profiling and Biomarker-Directed Therapies
CME/CEThe Future of mCSPC: Molecular Profiling and Biomarker-Directed Therapies
From Prevalence to Practice: Practical Screening and Workup for Hypercortisolism in Resistant Hypertension
CME/CEFrom Prevalence to Practice: Practical Screening and Workup for Hypercortisolism in Resistant Hypertension
- advertisement
Translating Evidence Into Action: Nonsteroidal MRAs in Patients With HF
CME/CETranslating Evidence Into Action: Nonsteroidal MRAs in Patients With HF
Reimagining Alzheimer's Care: The Advent of Subcutaneous Administration of Anti-Amyloid Therapy
CME/CEReimagining Alzheimer's Care: The Advent of Subcutaneous Administration of Anti-Amyloid Therapy
Engaging Adult Patients With C3GN: Shared Decision-Making at the Crossroads of Complement-Targeted Therapy
CME/CEEngaging Adult Patients With C3GN: Shared Decision-Making at the Crossroads of Complement-Targeted Therapy

































































